Oribiotech
Automated bioreactor and manufacturing platform for cell and gene therapy developers and manufacturers
Highlights
- New on EvolcAdded 2026-10-27
About Oribiotech
Oribiotech Ltd, trading as Ori Biotech, develops the IRO® platform for manufacturing cell and gene therapies (CGT). The platform combines a bioreactor, Ori Connect automated sterile connection technology and a cloud-native digital platform that covers process development through GMP manufacturing.
Its customers are CGT developers and manufacturers. The company names Catalent as a member of its Preferred Partner Network and announced a 10-year, $120M partnership to move a commercial cell therapy onto the IRO platform with an undisclosed pharma partner.
The company is registered in England and Wales and is headquartered in London. It was founded on 2 September 2015. Its leadership includes Jason Foster (CEO) and Farlan Veraitch (founder and Chief Scientific Officer).
Product: IRO® bioreactor and automated manufacturing platform with Ori Connect sterile connection technology and a cloud-native digital platform for cell and gene therapy production
Jobs at Oribiotech
Leadership
- Chris Mason · Co-Founder and Scientific AdvisorSource: company website
- Jason C. Foster · Chief Executive Officer and Executive DirectorSource: company website
- Ashley Barton · Finance DirectorSource: company website
- Farlan Veraitch · Founder and Chief Scientific Officer - Board ObserverSource: company website
- Stuart Milne · Chief Technology OfficerSource: company website
- Sarah Parsons · Associate Director of HRSource: company website
- William Raimes · Head of Process DevelopmentSource: company website
More biotech & pharma companies
Orthoson
Develops an injectable implant to restore spinal disc mechanics for people with degenerative disc disease and back painNew on EvolcOttimo Pharma
Clinical-stage biotech developing PD-1/VEGFR2 dual-paratopic antibodies for patients with cancerNew on EvolcOxsonics
Clinical-stage drug delivery company developing SonoTran, an ultrasound platform that boosts anti-cancer drug penetration into solid tumoursNew on EvolcPathios Therapeutics
Develops GPR65-targeting cancer immunotherapies for patients with solid tumorsNew on EvolcPeptone
Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targetsNew on EvolcPetagene
Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teamsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Tag Manager
- Google reCAPTCHA
- HubSpot
- WordPress
- jQuery